| CAS登錄號 | 中文名 | 英文名 | 分子結構式 | 分子式 | 詳情 | 供應商 |
| 14453-93-1 | Benzo[g]pteridine-2,4(1H,3H)-dione,5-acetyl-10-ethyl-5,10-dihydro-1,3,7,8-tetramethyl-; Alloxazine,5-acetyl-10-ethyl-5,10-dihydro-1,3,7,8-tetramethyl- (7CI,8CI) |  | C18H22N4O3 | 詳情 | 供應商 | |
| 6035-61-6 | L-lyxo-Hexos-2-ulose,6-deoxy-, bis(phenylhydrazone) (9CI); Fucose,phenylosazone, L- (6CI); L-lyxo-Hexosulose, 6-deoxy-, bis(phenylhydrazone)(8CI); L-Fucose phenylosazone; NSC 405935 |  | C18H22N4O3 | 詳情 | 供應商 | |
| 212322-56-0 | 3-[(3-氨基-4-甲基氨基苯甲酰)吡啶-2-基氨基]丙酸乙酯; 3-[(3-氨基-4-甲基氨基苯甲酰)吡啶-2-基氨基]丙酸乙? | 3-[(3-AMINO-4-METHYLAMINO-BENZOYL)-PYRIDIN-2-YL-AMINO]-PROPIONIC ACID ETHYL ESTER; 3-[(3-AMINO-4-METHYLAMINO-BENZOYL)-PYRIDIN-2-YL-AMINO]-PROPIONIC ACID ETHYL ESTER; N-[3-amino-4-(methylamino)benzoyl]-N-2-pyridinyl-β-Alanine,ethylester; Ethyl 3-(3-amino-4-(methylamino)-N-(pyridin-2-yl)benzamido)propanoate; Dabigatran Intermediate 1 |  | C18H22N4O3 | 詳情 | 供應商 |